Torrent Pharmaceuticals share news, announcements and annual reports
NSE: TORNTPHARMBSE: 500420Pharmaceuticals & BiotechnologyLarge Cap
Share price at the NSE close on 30 Oct 2026. Previous close ₹4,580.00.
30 Oct: open ₹4,560.00, high ₹4,672.00, low ₹4,532.00
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹1,75,479 Cr61st largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 82.62
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 9.55
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.82%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 15.8%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 12.0%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Sep 2026.
- 0.76
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 4,36,64564.6% delivered
Torrent Pharmaceuticals share news and announcements
865 announcements, routine notices left out, newest first. Page 8 of 18.
Dec 2021
14 Dec · Redemption
13 Dec · Redemption
Nov 2021
29 Nov · Analysts
11 Nov · Analysts
Oct 2021
26 Oct · Results
11 Oct · Board meeting
Sep 2021
24 Sep · Analysts
18 Sep · Analysts
13 Sep · Analysts
Aug 2021
31 Aug · Rating
Jul 2021
27 Jul · Meeting
27 Jul · Results
17 Jul · Analysts
9 Jul · Board meeting
Jun 2021
9 Jun · Analysts
3 Jun · Analysts
May 2021
26 May · Analysts
18 May · Corporate action
18 May · Dividend
18 May · Results
10 May · Analysts
6 May · Rating
Apr 2021
28 Apr · Annual Disclosure
23 Apr · Redemption
7 Apr · Disclosure
Mar 2021
25 Mar · Business
3 Mar · Analysts
Feb 2021
16 Feb · Analysts
8 Feb · Dividend
8 Feb · Results
Jan 2021